Impact of the Procurement Technique on Outcomes After Liver Transplantation
Starting soon
Conditions studied: Liver Transplantation
In brief
Liver transplantation (LT) is the standard treatment for hepatocellular carcinoma (HCC) and end-stage liver disease, with excellent long-term outcomes despite the increasing use of extended criteria donors due to organ shortage. As traditional evaluation criteria have become insufficient, new indicators such as Arterial and Biliary Complication-Free Survival (ABCFS) have been developed to better assess post-transplant outcomes. Primary objective: To assess, in a large-scale study, whether the procurement technique influences liver transplantation outcomes in terms of arterial and biliary complication-free survival.
Key facts
- Study ID
- NCT07582978
- Run by
- Assistance Publique - Hôpitaux de Paris
- People needed
- 1810
- Starts
- 2026-09-01
- Expected to finish
- 2031-09-01
- Last updated by the study team
- 2026-05-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aged 18 years or older at the time of inclusion
- Listed on the national waiting list of the Agence de la Biomédecine (ABM)
- Undergoing a first liver transplantation in France
- Receiving a whole liver graft
- No prior or subsequent transplantation of another organ
You may not qualify if…
- Pancreas procurement
- Multiorgan transplantation
- Split liver transplantation (shared grafts)
- Retransplantation
- Domino transplantation (no actual organ procurement in the conventional sense)
- Patient refusal to allow the use of their data
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.